Source: Bipartisan Policy Center (2025)
Bipartisan Policy Center (2025). Overview of FDA's regulatory approach to AI/ML in healthcare, including discussion of Good Machine Learning Practices (GMLP) and synthetic data in model development.

Bipartisan Policy Center (2025). Overview of FDA's regulatory approach to AI/ML in healthcare, including discussion of Good Machine Learning Practices (GM…
Source: Bipartisan Policy Center (2025)
Bipartisan Policy Center (2025). Overview of FDA's regulatory approach to AI/ML in healthcare, including discussion of Good Machine Learning Practices (GMLP) and synthetic data in model development.